KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 14 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,888,000 | -58.5% | 2,517,000 | -44.3% | 0.00% | -50.0% |
Q2 2021 | $4,550,000 | +761.7% | 4,517,000 | +773.7% | 0.00% | – |
Q1 2021 | $528,000 | -91.5% | 517,000 | -89.7% | 0.00% | -100.0% |
Q4 2020 | $6,243,000 | +5.4% | 5,017,000 | +0.5% | 0.00% | -25.0% |
Q3 2020 | $5,921,000 | – | 4,994,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 8,000,000 | $5,215,000 | 9.09% |
BRAIDWELL LP | 65,976,000 | $40,943,996 | 1.29% |
Context Capital Management, LLC | 21,494 | $13,329 | 1.07% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,500,000 | $20,663,750 | 0.86% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $15,264,731 | 0.20% |
DeepCurrents Investment Group LLC | 4,250,000 | $2,700,994 | 0.12% |
CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $4,654,419 | 0.02% |
Verition Fund Management LLC | 1,359 | $843,381 | 0.01% |
LAZARD ASSET MANAGEMENT LLC | 6,500,000 | $4,033 | 0.01% |
BLB&B Advisors, LLC | 75,000 | $45,794 | 0.00% |